Why Nobel laureate David Baltimore doesn’t support moratorium on CRISPR babies

4-3-2019 maxresdefault
Image: CalTech

Some scientists have recently proposed a temporary moratorium on editing that would result in babies that carry heritable changes.

Science News talked with Nobel laureate David Baltimore, who is president emeritus of Caltech, about the ongoing debate. Baltimore, a virologist and immunologist, chaired two international summits on human gene editing. The interview has been edited for brevity and clarity.

SN: You’ve come out in the past as not being in favor of a moratorium. Why?

ADVERTISEMENT

Baltimore: It’s largely a semantic issue. Statements made after the first summit and the second summit have avoided using the term moratorium. Consciously. Because that word has been associated with very firm rules about what you can do and what you can’t do.

Related article:  Sustainable bacon: CRISPR-edited pigs could survive deadly disease, but public support key to success

With a science that’s moving forward as rapidly as this science is, you want to be able to adapt to new discoveries, new opportunities and new understandings. To make rules is probably not a good idea.

What’s a good idea is to be on top of a changing environment and to adjust to it as time goes by. And that’s both an ethical environment and a practical environment of the mechanics of gene editing.

ADVERTISEMENT
ADVERTISEMENT

Read full, original post: A Nobel Prize winner argues banning CRISPR babies won’t work

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend